Lieferengpass-Meldepflicht & Lagerhaltung ohne Automatisierung
Definition
ALBVVG (Arzneimittel-Lieferengpassbekämpfungs- und Versorgungsverbesserungsgesetz) now requires mandatory shortage reporting and, for pediatric/generic medicines, 6-month stockpiling commitments in rebate agreements. A pharmacy without automated shortage tracking must manually verify stock levels, email BfArM, and document proof. Manual process: 2–3 hours/day (shortage verification + notification + confirmation). Cost: €30/hour × 150 hours/year = €4,500/year. Penalty for late/missed reporting: €5,000–€50,000 per incident (BfArM discretion).
Key Findings
- Financial Impact: €4,500–€6,000/year manual process overhead; €5,000–€50,000 per missed shortage report (penalty)
- Frequency: Daily (stock monitoring); Weekly (BfArM submissions); Quarterly (Betriebsprüfung audit risk)
- Root Cause: No integrated shortage-alert system; manual BfArM portal submissions; no automated compliance audit trail.
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Retail Pharmacies.
Affected Stakeholders
Warehouse Manager, Pharmacy Manager, Compliance Officer
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Apothekenrabatt-Margin-Erosion durch Regeländerung
ePA-Dokumentationspflicht & Datenschutzverstöße durch manuelle Verarbeitung
Import-Arzneimittel: UK-Kennzeichnung & RPi-Compliance-Overhead
HTA/AMNOG-Dokumentation für Apotheken-Reimbursement-Verhandlungen
Fehlende Abrechnung von Zuschlägen bei Generika-Substitution
Abweichungen in der Berechnung der obligatorischen Apothekenrabatte
Request Deep Analysis
🇩🇪 Be first to access this market's intelligence